direct regulation of mlkl by efhd2 to suppress the...

1
Direct Regulation of MLKL by EFhd2 to Suppress the Necrotic Signaling Pathway JK Huff , PJ Klutho and CP Baines Department of Biomedical Sciences, Dalton Cardiovascular Research Center University of Missouri, Columbia, MO 65211 BACKGROUND EXPERIMENT OVERVIEW & OBJECTIVES RESULTS MLKL Mediates TNFα-induced Necrosis but where does EFhd2 regulate MLKL? Programmed cell death plays a vital role in both physiological and pathological processes from embryogenesis to disease pathogenesis in multiple organs such as liver cirrhosis and renal failure. Thus researching how necrosis is signaled is vital for advancing the treatment of multiple diseases. Necrosis occurs when tumor necrosis factor (TNF) receptors on cells are activated leading to the phosphorylation and activation of the kinases Receptor Interacting Protein 1 and 3 (RIP1 and RIP3). RIP3 then binds to and phosphorylates the pseudokinase Mixed Lineage Kinase domain-Like protein (MLKL). Phosphorylated MLKL then oligomerizes and translocates to the plasma membrane where it forms a non- specific pore that kills the cell. We have previously identified EF-hand domain family member 2 (EFhd2) as a novel MLKL-binding protein and shown that it can suppress TNF-induced necrosis. However, the molecular mechanism by which EFhd2 inhibits necrosis remains to be elucidated Knockdown of EFhd2 increases TSZ induced cell death ACKNOWLEDGEMENTS Supported by NIH R01 HL094404 and an endowment established by IDEXX-BioResearch. Overexpression of EFhd2 protects against TSZ induced cell death CONCLUSIONS & FUTURE STUDIES Infect wildtype (WT) mouse embryonic fibroblasts (MEFs) with adenoviral EFhd2 (overexpression) or transfect WT MEFS with siEFhd2 (knockdown). Induce cell death with mixture of TNF/ SMAC mimetic/zVAD (TSZ). Stain with sytox and image cellular death and total cells. Harvest and lyse cells. Run Western blot evaluating phosphorylated (activated) MLKL, pRIP1 and pRIP3. Figure 2: Knockdown of siEFhd2 increases cell death induced by TSZ. Representative images (A) and quantification (B) of WT MEFs transfected with siRNA against EFhd2 or siCTL for 48 hours. Cells were then treated with (20μg/mLTNF-α, 1μM SMAC mimetic, 20μM ZVAD) of TSZ for 2 hours before analysis of cell death by sytox imaging. Blue bars represent individual experiments and gray bars represent mean +/- standard deviation. siCTL Composite siEFhd2 Hoeschst Sytox Figure 3: Knockdown of EFhd2 affects pRIP1 & pRIP3 levels. WT MEFs were transfected with siRNA against EFhd2 or siCTL for 48 hours. The cells were collected and lysed for Western blot analysis of the RIP1/RIP3/MLKL pathway. n=1 EFhd2 regulates TSZ induced cell death. Knockdown increases cell death. Overexpression decreases cell death. EFhd2 is an upstream regulator of MLKL activation. Western blot analysis reveals a difference in pRIP1 and pRIP3 with EFhd2 augmentation. Western blot analysis needs to be repeated for conformation of current results. Further studies will be performed on direct regulation of pRIP1 and pRIP3 to conclude EFhd2 regulation of the pathway does not involve direct inhibition of MLKL. 0 10 20 30 40 50 60 70 80 90 siCTL control siEFhd2 control siCTL TSZ siEFhd2 TSZ % sytox postive B. 0 10 20 30 40 50 60 70 80 90 βgal control EFhd2 control βgal TSZ EFhd2 TSZ % sytox positve p=0.0185 siCTL siEFhd2 Control TSZ Composite Hoeschst Sytox Control TSZ p=0.112 βgal EFhd2 βgal EFhd2 siCTL siEFhd2 Control TSZ Control TSZ p RIP1 p RIP3 p MLKL MLKL RIP1 RIP3 Control TSZ Control TSZ βgal EFhd2 P RIP1 p RIP3 p MLKL MLKL RIP1 RIP3 Figure 5: Overexpression of EFhd2 protects against cell death induced by TSZ. Representative images (A) and quantification (B) of WT MEFs infected with viral EFhd2 or βgal (control virus) for 48 hours. Cells were then treated with (20μg/ml TNF-α, 1μM SMAC mimetic, 20μM ZVAD) of TSZ for 2 hours before analysis of cell death by sytox imaging. Blue bars represent individual experiments and gray bars represent mean +/- standard deviation. Figure 6: Overexpression of EFhd2 affects pRIP1 & pRIP3 levels. WT MEFs were infected with EFhd2 or Bgal for 48 hours. The cells were collected and lysed for Western blot analysis of the RIP1/RIP3/MLKL pathway. n=1 TNFα TNFR RIP1 RIP3 MLKL EFhd2 NECROSIS ? Figure 1: siEFhd2 has sufficient knockdown of EFhd2 protein. Western blot analysis of WT MEFs transfected with siRNA against EFhd2 or scrambled control (CTL). A. Figure 4: EFhd2 virus has sufficient expression of EFhd2 protein. Western blot analysis of WT MEF infected with EFhd2 or βgal adenovirus. B. A.

Upload: doanxuyen

Post on 28-Mar-2019

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Direct Regulation of MLKL by EFhd2 to Suppress the ...vrsp.missouri.edu/wp-content/uploads/2017/01/Huff.pdf · Direct Regulation of MLKL by EFhd2 to Suppress the Necrotic Signaling

Direct Regulation of MLKL by EFhd2 to Suppress the Necrotic Signaling Pathway

JK Huff, PJ Klutho and CP Baines

Department of Biomedical Sciences, Dalton Cardiovascular Research CenterUniversity of Missouri, Columbia, MO 65211

BACKGROUND

EXPERIMENT OVERVIEW & OBJECTIVES

RESULTS

MLKL Mediates TNFα-induced Necrosis but where does EFhd2 regulate MLKL?

Programmed cell death plays a vital role in both physiologicaland pathological processes from embryogenesis to diseasepathogenesis in multiple organs such as liver cirrhosis andrenal failure. Thus researching how necrosis is signaled is vitalfor advancing the treatment of multiple diseases.

Necrosis occurs when tumor necrosis factor (TNF) receptorson cells are activated leading to the phosphorylation andactivation of the kinases Receptor Interacting Protein 1 and 3(RIP1 and RIP3). RIP3 then binds to and phosphorylates thepseudokinase Mixed Lineage Kinase domain-Like protein(MLKL). Phosphorylated MLKL then oligomerizes andtranslocates to the plasma membrane where it forms a non-specific pore that kills the cell.

We have previously identified EF-hand domain familymember 2 (EFhd2) as a novel MLKL-binding protein andshown that it can suppress TNF-induced necrosis. However,the molecular mechanism by which EFhd2 inhibits necrosisremains to be elucidated

ConttrolKnockdown of EFhd2 increases TSZ

induced cell death

ACKNOWLEDGEMENTS

Supported by NIH R01 HL094404 and an endowment established by IDEXX-BioResearch.

Overexpression of EFhd2 protects

against TSZ induced cell death

CONCLUSIONS & FUTURE STUDIES

Infect wildtype (WT) mouse embryonic fibroblasts

(MEFs) with adenoviral EFhd2 (overexpression) or transfect WT MEFS with siEFhd2 (knockdown).

Induce cell death with mixture of TNF/ SMAC mimetic/zVAD (TSZ).

Stain with sytox and image cellular death and total cells.

Harvest and lyse cells.

Run Western blot evaluating

phosphorylated (activated) MLKL, pRIP1

and pRIP3.

Figure 2: Knockdown of siEFhd2 increases cell death induced by TSZ. Representative images (A) and quantification (B) of WT MEFs transfected with siRNA against EFhd2 or siCTL for 48 hours. Cells were then treated with (20μg/mLTNF-α, 1μM SMAC mimetic, 20μM ZVAD) of TSZ for 2 hours before analysis of cell death by sytox imaging. Blue bars represent individual experiments and gray bars represent mean +/- standard deviation.

siCTL

Co

mp

osi

te

siEFhd2

Ho

esch

st

Syto

x

Figure 3: Knockdown of EFhd2 affects pRIP1 & pRIP3 levels. WT MEFs were transfected with siRNA against EFhd2 or siCTL for 48 hours. The cells were collected and lysed for Western blot analysis of the RIP1/RIP3/MLKL pathway. n=1

EFhd2 regulates TSZ induced cell death. Knockdown increases cell death. Overexpression decreases cell death.

EFhd2 is an upstream regulator of MLKL activation. Western blot analysis reveals a difference in pRIP1 and pRIP3 with EFhd2 augmentation.

Western blot analysis needs to be repeated for conformation of current results. Further studies will be performed on direct regulation of pRIP1 and pRIP3 to conclude EFhd2 regulation of the

pathway does not involve direct inhibition of MLKL.

0

10

20

30

40

50

60

70

80

90

siCTL control siEFhd2 control siCTL TSZ siEFhd2 TSZ

% s

yto

x p

ost

ive

B.

0

10

20

30

40

50

60

70

80

90

βgal control EFhd2 control βgal TSZ EFhd2 TSZ

% s

yto

x p

osi

tve

p=0.0185

siCTL siEFhd2

Control TSZ

Co

mp

osi

teH

oes

chst

Syto

x

Control TSZ

p=0.112

βgal EFhd2 βgal EFhd2

siCTL siEFhd2

Control TSZ Control TSZ

p RIP1

p RIP3

p MLKL

MLKL

RIP1

RIP3

Control TSZ Control TSZ

βgal EFhd2

P RIP1

p RIP3

p MLKL

MLKL

RIP1

RIP3

Figure 5: Overexpression of EFhd2 protects against cell death induced by TSZ. Representative images (A) and quantification (B) of WT MEFs infected with viral EFhd2 or βgal (control virus) for 48 hours. Cells were then treated with (20μg/ml TNF-α, 1μM SMAC mimetic, 20μM ZVAD) of TSZ for 2 hours before analysis of cell death by sytox imaging. Blue bars represent individual experiments and gray bars represent mean +/- standard deviation.

Figure 6: Overexpression of EFhd2 affects pRIP1 & pRIP3 levels. WT MEFs were infected with EFhd2 or Bgal for 48 hours. The cells were collected and lysed for Western blot analysis of the RIP1/RIP3/MLKL pathway. n=1

TNFα

TNFR

RIP1

RIP3

MLKL

EFhd2

NECROSIS

?

Figure 1: siEFhd2 has sufficient knockdown of EFhd2 protein. Western blot analysis of WT MEFs transfected with siRNA against EFhd2 or scrambled control (CTL).

A.

Figure 4: EFhd2 virus has sufficient expression of EFhd2 protein. Western blot analysis of WT MEF infected with EFhd2 or βgal adenovirus.

B.

A.